COMBINATION CHEMOTHERAPY WITH 4' DEMETHYLEPIPODOPHYLLOTOXIN 9-(4,6-0-ETHYLIDENE-BETA-D-GLUCOPYRANOSIDE), VP-16-213 (NSC-141540) IN L1210 LEUKEMIA

被引：77

作者：

DOMBERNOWSKY, P ^{[1
]}

NISSEN, NI ^{[1
]}

机构：

[1] FINSEN INST,DEPT INTERN MED,DK-2100 COPENHAGEN,DENMARK

来源：

EUROPEAN JOURNAL OF CANCER | 1976年 / 12卷 / 03期

关键词：

D O I：

10.1016/0014-2964(76)90239-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：181 / 188

页数：8

共 22 条

[1] TREATMENT OF SMALL CELL ANAPLASTIC CARCINOMA OF LUNG WITH ORAL SOLUTION OF VP-16-213 (NSC 141540, 4'-DEMETHYLEPIPODOPHYLLOTOXIN 9-(4,6-0-ETHYLIDENE-BETA-D-GLUCOPYRANOSIDE)
HANSEN, M
HIRSCH, F
DOMBERNOWSKY, P
HANSEN, HH
CANCER, 1977, 40 (02) : 633 - 637
[2] PHASE-1 CLINICAL TRIAL OF WEEKLY ADMINISTRATION OF 4'-DEMETHYLEPIPODOPHYLLOTOXIN 9-(4,6-O-ETHYLIDENE-BETA-D-GLUCOPYRANOSIDE) (NSC-141540 - VP-16-213)
CREAVEN, PJ
NEWMAN, SJ
SELAWRY, OS
COHEN, MH
PRIMACK, A
CANCER CHEMOTHERAPY REPORTS PART 1, 1974, 58 (06): : 901 - 907
[3] PHASE I CLINICAL TRIAL OF A NEW ANTITUMOR AGENT, 4'-DEMETHYLEPIPODOPHYLLOTOXIN 9-(4,6-O-ETHYLIDENE-BETA-D-GLUCOPYRANOSIDE) (NSC-141540 - VP-16-213)
NISSEN, NI
LARSEN, V
PEDERSEN, H
THOMSEN, K
CANCER CHEMOTHERAPY REPORTS PART 1, 1972, 56 (06): : 769 - 777
[4] 4'-DEMETHYLEPIPODOPHYLLOTOXIN 9-(4,6-0-2-THENYLIDENE-BETA-D-GLUCOPYRANOSIDE) (NSC-122819-VM-26) AND 4'- DEMETHYLEPIPODOPHYLLOTOXIN 9-(486-0-ETHYLIDENE-BETA-D-GLUCOPYRANOSIDE) (NSC-141540-VP-16-213) IN CHILDHOOD CANCER - PRELIMINARY OBSERVATIONS
RIVERA, G
AVERY, T
PRATT, C
CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (04): : 743 - 749
[5] CLINICAL-STUDY OF NEW PODOPHYLLOTOXIN DERIVATIVE, 4'-DEMETHYLEPIPODOPHYLLOTOXIN-9-(4,6-0-ETHYLIDENE-BETA-D-GLUCOPYRANOSIDE) (NSC-141540-VP-16-213), IN SOLID TUMORS IN MAN
JUNGI, WF
SENN, HJ
CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (04): : 737 - 742
[6] PHASE-I CLINICAL TRIAL OF 4'-DEMETHYL EPIPODOPHYLLOTOXIN 9-(4,6-0-ETHYLIDENE BETA-D-GLUCOPYRANOSIDE) (NSC 141540, VP 16-213)
NEWMAN, SJ
CREAVEN, PJ
SELAWRY, OS
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 132 - 132
[7] COMPARISON OF CNS PENETRATION, TISSUE DISTRIBUTION, AND PHARMACOLOGY OF 4'-DEMETHYL EPIPODOPHYLLOTOXIN 9-(4,6-0-ETHYLIDENE-BETA-D-GLUCOPYRANOSIDE) (VP-16, NSC-141540) INTRA-CAROTID (IC) VS INTRAVENOUS ADMINISTRATION (IV) IN DOGS
SAVARAJ, N
LU, K
RAULSTON, GL
FEUN, LG
LOO, TL
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 201 - 201
[8] SCHEDULE DEPENDENCY OF ANTILEUKEMIC ACTIVITY OF PODOPHYLLOTOXIN-DERIVATIVE VP 16-213 (NSC-141540) IN L1210 LEUKEMIA
DOMBERNOWSKY, P
NISSEN, NI
ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA SECTION A-PATHOLOGY, 1973, A 81 (05): : 715 - 724
[9] ANALYSIS OF 4'-DEMETHYLEPIPODOPHYLLOTOXIN-9-(4,6-0-ETHYLIDENE-BETA-D-GLUCOPYRANOSIDE) BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY
ALLEN, LM
JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (12) : 1440 - 1441
[10] CLINICAL TRIAL OF ORAL FORM 4'-DEMETHYL-EPIPODOPHYLLOTOXIN-BETA-D ETHYLIDENE GLUCOSIDE (NSC-141540) VP 16-213
FALKSON, G
FALKSON, H
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 160 - 160

← 1 2 3 →